Editorials

Metered dose inhalers free of chlorofluorocarbons

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6981.684 (Published 18 March 1995) Cite this as: BMJ 1995;310:684
  1. Martyn Partridge,
  2. Ashley Woodcock
  1. Consultant chest physician Whipps Cross Hospital, London E11 INR
  2. Consultant chest physician North West Lung Centre, Wythenshawe Hospital, Manchester M23 9LT

    Doctors can ease their introduction

    The metered dose inhaler, which is used by patients with asthma and chronic obstructive pulmonary disease, is about to undergo some substantial changes. Health professionals need to know why and how these changes are occurring so that they can ease their patients' transition from old to new.

    The reason for the changes lies in the thinning of the ozone layer in the stratosphere. The possibility that chlorofluorocarbons, which are widely used as aerosol propellants and refrigerants, might deplete stratospheric ozone was first suggested 20 years ago.1 This caused concern because reduction of the ozone layer would permit increased exposure to ultraviolet B radiation, with the possibility of increased rates of skin cancer and cataracts and other less obvious effects on the immune system, vegetation, and plant and animal growth.2 3 Such postulated thinning had been confirmed over Antarctica by 1986. Government action had, however, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe